Information:
Fel:
ID
29138
Beskrivning
Assessment of Insulin Glargine in Type 2 Patients for Good Glycemic Control; ODM derived from: https://clinicaltrials.gov/show/NCT00701831
Länk
https://clinicaltrials.gov/show/NCT00701831
Nyckelord
Versioner (1)
- 2018-02-28 2018-02-28 -
Rättsinnehavare
See clinicaltrials.gov
Uppladdad den
28 februari 2018
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Diabetes Mellitus, Type 2 NCT00701831
Eligibility Diabetes Mellitus, Type 2 NCT00701831
- StudyEvent: Eligibility
Similar models
Eligibility Diabetes Mellitus, Type 2 NCT00701831
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Diabetes Mellitus, Non-Insulin-Dependent | Insulin naive
Item
t2 insulin naïve patients
boolean
C0011860 (UMLS CUI [1])
C0021641 (UMLS CUI [2,1])
C0919936 (UMLS CUI [2,2])
C0021641 (UMLS CUI [2,1])
C0919936 (UMLS CUI [2,2])
Lantus Initiation considering
Item
patients whom their physician is considering initiation of lantus treatment
boolean
C0876064 (UMLS CUI [1,1])
C1704686 (UMLS CUI [1,2])
C0750591 (UMLS CUI [1,3])
C1704686 (UMLS CUI [1,2])
C0750591 (UMLS CUI [1,3])
Poor glycemic control Percentage
Item
poor glycemic control 7,5 %10 %
boolean
C0342299 (UMLS CUI [1,1])
C0439165 (UMLS CUI [1,2])
C0439165 (UMLS CUI [1,2])
Therapeutic procedure Non-Insulin-Dependent Diabetes Mellitus | Antidiabetics Oral
Item
t2 treatment with oads more than 3 months
boolean
C0087111 (UMLS CUI [1,1])
C0011860 (UMLS CUI [1,2])
C0935929 (UMLS CUI [2,1])
C1527415 (UMLS CUI [2,2])
C0011860 (UMLS CUI [1,2])
C0935929 (UMLS CUI [2,1])
C1527415 (UMLS CUI [2,2])
Body mass index
Item
bmi<40 kg/m2
boolean
C1305855 (UMLS CUI [1])
Renal Insufficiency | Creatinine measurement, serum | Dialysis
Item
impaired renal function (cr>2mg/dl or current renal dialysis)
boolean
C1565489 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
C0011946 (UMLS CUI [3])
C0201976 (UMLS CUI [2])
C0011946 (UMLS CUI [3])
Metabolic acidosis | Chronic metabolic acidosis
Item
acute or chronic metabolic acidosis
boolean
C0220981 (UMLS CUI [1])
C0740749 (UMLS CUI [2])
C0740749 (UMLS CUI [2])
Liver disease | Alanine aminotransferase increased | Aspartate aminotransferase increased
Item
active liver disease or serum alt or ast >2,5 than normal
boolean
C0023895 (UMLS CUI [1])
C0151905 (UMLS CUI [2])
C0151904 (UMLS CUI [3])
C0151905 (UMLS CUI [2])
C0151904 (UMLS CUI [3])
Loss of hypoglycemic warning
Item
history of hypoglycemia unawareness
boolean
C0342317 (UMLS CUI [1])
Diabetic Retinopathy | Operative Surgical Procedures | Operative Surgical Procedures Planned
Item
diabetic retinopathy with surgery in the previous 3 months or planned within 3 months after study entry
boolean
C0011884 (UMLS CUI [1])
C0543467 (UMLS CUI [2])
C0543467 (UMLS CUI [3,1])
C1301732 (UMLS CUI [3,2])
C0543467 (UMLS CUI [2])
C0543467 (UMLS CUI [3,1])
C1301732 (UMLS CUI [3,2])
Pregnancy | Breast Feeding
Item
pregnancy, breast feeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
Study Subject Participation Status Aspect Additional
Item
the above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
boolean
C2348568 (UMLS CUI [1,1])
C1879746 (UMLS CUI [1,2])
C1524062 (UMLS CUI [1,3])
C1879746 (UMLS CUI [1,2])
C1524062 (UMLS CUI [1,3])